Inactive Instrument
CTT Pharmaceutical Holdings, Inc. Stock Other OTC
Stocks
CTTH
US12651E1064
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.28M 2.92M 2.73M 2.47M 4.67M 317M 4.7M 32.77M 12.75M 162M 12.33M 12.07M 519M | P/E 2024 |
-11.9x | P/E 2025 | -22.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.29M 2.92M 2.73M 2.48M 4.68M 317M 4.71M 32.81M 12.76M 162M 12.34M 12.08M 520M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
50.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -22.52% |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryan Khouri
CEO | Chief Executive Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Allen Greenspoon
BRD | Director/Board Member | 71 | 09/09/2014 |
Ryan Khouri
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -22.52% | -0.09% | - | - | 3.28M | ||
| +4.16% | +3.42% | +49.37% | +94.17% | 74.31B | ||
| +2.76% | -1.60% | +22.80% | +78.53% | 56.95B | ||
| +0.24% | -1.34% | +3.41% | +34.31% | 48.3B | ||
| -4.04% | -2.06% | +329.93% | +699.76% | 44.51B | ||
| -0.88% | -1.76% | +28.89% | +33.03% | 43.8B | ||
| +1.25% | +0.02% | +6.04% | +110.10% | 41.12B | ||
| -0.11% | +2.30% | +9.19% | +58.68% | 31.07B | ||
| +4.51% | +8.43% | +37.27% | +34.97% | 28.97B | ||
| -1.07% | -0.76% | -6.98% | -12.04% | 24.53B | ||
| Average | -1.56% | -0.20% | +53.32% | +125.72% | 43.73B | |
| Weighted average by Cap. | +1.06% | -0.50% | +57.24% | +134.14% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -250K -222K -208K -188K -356K -24.12M -358K -2.5M -971K -12.31M -939K -919K -39.56M | -156K -138K -130K -117K -222K -15.03M -223K -1.56M -605K -7.67M -585K -573K -24.65M |
| Net Debt | 16.82K 14.93K 13.97K 12.66K 23.92K 1.62M 24.09K 168K 65.27K 827K 63.13K 61.78K 2.66M | 3.46K 3.07K 2.87K 2.6K 4.91K 333K 4.95K 34.47K 13.41K 170K 12.97K 12.69K 546K |
Employees
-
















